Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1992 Dec;38(12):1429-35.

[Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients]

[Article in Japanese]
H Ueyama  1 , H Nakahashi, K Sawanishi, M Kuze, T Ono
Affiliations
  • PMID: 1288237
Free article
Clinical Trial

[Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients]

[Article in Japanese]
H Ueyama et al. Hinyokika Kiyo. 1992 Dec.
Free article

Abstract

Recombinant human erythropoietin was administered to 59 patients over 65 years of age receiving maintenance hemodialysis treatment in Kyoto and Shiga district, in order to evaluate its utility on renal anemia. After 6 months of administration, the hematocrit rose from 20.8 +/- 3.5% to 28.0 +/- 3.7% with concomitant improvement of subjective symptoms related to anemia. Twelve patients developed side effects, in 10 of whom elevation of blood pressure was observed. We found no clinically significant abnormalities in the laboratory data. In conclusion, recombinant human erythropoietin is highly useful in the treatment of renal anemia in elderly hemodialysis patients.

PubMed Disclaimer